TEEPLE, A.; MUSER, E. Cost Per Responder Analysis of Guselkumab versus Adalimumab using Efficacy Results fromm a Head-to-Head Clinical Trial in Patients with Moderate to Severe Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 1, n. 3.1, p. s6, 2017. DOI: 10.25251/skin.1.supp.5. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/157. Acesso em: 23 jul. 2024.